Neurological disorders

Neuronax is a biopharmaceutical company dedicated to developing first-in-class disease-modifying drugs to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs.

Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders.

NX210, our lead product, is a first-in-class multi-target peptide with high potential and promising preclinical results in many CNS disorders.